Evidence map›Paper›PMID 28148596›Full record

ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2017

Longitudinal Changes in Volumetric Breast Density with Tamoxifen and Aromatase Inhibitors.

Natalie J Engmann, Christopher G Scott, Matthew R Jensen, Lin Ma, Kathleen R Brandt, Amir Pasha Mahmoudzadeh, Serghei Malkov, Dana H Whaley, Carrie B Hruska, Fang Fang Wu and 8 more

Abstract read
In one paragraph

Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 53 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Breast Cancer Population Attributable Risk Proportions Associated with Body Mass Index and Breast Density by Race/Ethnicity and Menopausal Status.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 3 institutions in 1 country.

Natalie J EngmannUniversity of California, San Francisco, San Francisco, California. natalie.engmann@ucsf.edu.
Christopher G ScottMayo Clinic, Rochester, Minnesota.
Matthew R JensenMayo Clinic, Rochester, Minnesota.
Lin MaUniversity of California, San Francisco, San Francisco, California.
Kathleen R BrandtMayo Clinic, Rochester, Minnesota.
Amir Pasha MahmoudzadehUniversity of California, San Francisco, San Francisco, California.
Serghei MalkovUniversity of California, San Francisco, San Francisco, California.
Dana H WhaleyMayo Clinic, Rochester, Minnesota.
Carrie B HruskaMayo Clinic, Rochester, Minnesota.
Fang Fang WuMayo Clinic, Rochester, Minnesota.
Stacey J WinhamMayo Clinic, Rochester, Minnesota.
Diana L MigliorettiUniversity of California, Davis, Davis, California.
Aaron D NormanMayo Clinic, Rochester, Minnesota.
John J HeineMoffitt Cancer Center, Tampa, Florida.
John ShepherdUniversity of California, San Francisco, San Francisco, California.
V Shane PankratzUniversity of New Mexico Health Sciences Center, Albuquerque, New Mexico.
Celine M VachonMayo Clinic, Rochester, Minnesota.
Karla KerlikowskeUniversity of California, San Francisco, San Francisco, California.
Mayo Clinic · USUniversity of California, San Francisco · USMoffitt Cancer Center · US

Funding

Staff InvestigatorsP30CA093373 · NCI · UNIVERSITY OF CALIFORNIA DAVIS · PI Gina M Dayton · 2002 to 2026
$84.9M
Risk-based Imaging Strategies to Improve Breast Cancer Surveillance OutcomesP01CA154292 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI KARLA M KERLIKOWSKE · 2011 to 2026
$52.9M
The Role of CHFR in Tumorigenesis and Paclitaxel-Sensitivity in Breast CancerP50CA116201 · NCI · MAYO CLINIC ROCHESTER · PI Fergus Joseph Couch · 2005 to 2026
$49.9M
Lesion Composition and Quantitative Imaging Analysis on Breast Cancer DiagnosisR01CA166945 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI GIGER, MARYELLEN L., SHEPHERD, JOHN ALAN · 2013 to 2017
$3.3M
Automated Density Measures for Estimating Breast Cancer Risk and Therapy ResponseR01CA177150 · NCI · MAYO CLINIC ROCHESTER · PI KERLIKOWSKE, KARLA M, VACHON, CELINE M · 2013 to 2017
$3.0M
NCI NIH HHS P01 CA154292NCI NIH HHS P30 CA093373NCI NIH HHS P50 CA116201NCI NIH HHS R01 CA166945NCI NIH HHS R01 CA177150
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdultAromatase InhibitorsBreast DensityFemaleHumansMiddle AgedTamoxifenAromatase InhibitorsTamoxifen

Identifiers

PMID28148596
PMCPMC5457346
OpenAlexW2585381429

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.